Coumaric Acid

Coumaric Acid

SCHEMBL21571613

Nc1ccccc1C(=O)O.O=C(O)/C=C/c1ccc(O)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.64
▸ ESR2 Q92731 3/20 0.64
▸ PKM P14618 3/20 0.64
▸ HCAR2 Q8TDS4 2/20 0.64
▸ TYR P14679 2/20 0.64
▸ CA12 O43570 2/20 0.64
▸ AKR1B10 O60218 2/20 0.64
▸ AKR1B1 P15121 2/20 0.64
▸ CA4 P22748 2/20 0.64
▸ CA6 P23280 2/20 0.64
▸ CA5A P35218 2/20 0.64
▸ CA7 P43166 2/20 0.64
▸ CA9 Q16790 2/20 0.64
▸ CA14 Q9ULX7 2/20 0.64
▸ CA5B Q9Y2D0 2/20 0.64
▸ CA1 P00915 1/20 0.64
▸ CA2 P00918 1/20 0.64
▸ CA3 P07451 1/20 0.64
▸ DPP4 P27487 1/20 0.64
▸ MAPT P10636 5/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamic Acid SCHEMBL11837266 0.91 MAPT (0.75) ESR1ESR2PKMHCAR2TYR
Cinnamic Acid SCHEMBL11837253 0.91 MAPT (0.75) ESR1ESR2PKMHCAR2TYR
SCHEMBL25190631 0.86 MAPT (0.78) ESR1ESR2PKMTYRAKR1B1
SCHEMBL25225496 0.86 MAPT (0.78) ESR1ESR2PKMTYRAKR1B1
Anthranilic Acid SCHEMBL9861296 0.83 MMP2 (0.61) PKMCA12CA4CA6CA7
Coumaric Acid SCHEMBL15014255 0.82 ESR1 (0.88) ESR1ESR2PKMHCAR2TYR
Coumaric Acid SCHEMBL23070211 0.82 ESR1 (0.88) ESR1ESR2PKMHCAR2TYR
Anthranilic Acid SCHEMBL23357449 0.82 MAPT (0.59) PKMHCAR2CA12CA4CA6
Anthranilic Acid SCHEMBL7633209 0.80 MMP2 (0.61) PKMCA12CA4CA6CA7
Cinnamic Acid SCHEMBL16982631 0.80 ESR1 (0.83) ESR1ESR2PKMHCAR2TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793569-A1 INCREASING BIOAVAILABILITY OF IRON WITH AVENANTHRAMIDE 2C The Quaker Oats Company (US) 2021-03-24 — — EP disclosed
US-20190350887-A1 INCREASING BIOAVAILABILITY OF IRON WITH AVENANTHRAMIDE 2c THE QUAKER OATS COMPANY 2019-11-21 — — US disclosed
Send feedback